Literature DB >> 24183236

G0S2 inhibits the proliferation of K562 cells by interacting with nucleolin in the cytosol.

Takeshi Yamada1, Chun Shik Park1, Ye Shen1, Karen R Rabin2, H Daniel Lacorazza3.   

Abstract

G0/G1 switch gene 2 (G0S2) is a basic protein with ill-defined function that inhibits the proliferation of hematopoietic stem cells. Herein, we show that treatment of K562 cells with 5-azacytidine (5-Aza) resulted in a 24-fold increase in G0S2 expression and a reduction in cell growth. Conversely, gene demethylation in the presence of G0S2-specific shRNA restored proliferation, further supporting an inhibitory role for G0S2 in cell proliferation. Elevated levels of G0S2 inhibited the division of K562 cells by sequestering the nucleolar phosphoprotein nucleolin in the cytosol. G0S2 inhibited the proliferation of leukemia cells in vivo in xenograft models. Collectively, our data identify a new mechanism that controls proliferation in K562 cells, suggesting a possible tumor suppressor function in leukemia cells.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  G0S2; K562; Nucleolin; Proliferation

Mesh:

Substances:

Year:  2013        PMID: 24183236      PMCID: PMC3946941          DOI: 10.1016/j.leukres.2013.10.006

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  30 in total

Review 1.  DNA methylation and gene silencing in cancer.

Authors:  Stephen B Baylin
Journal:  Nat Clin Pract Oncol       Date:  2005-12

2.  The G0/G1 switch gene 2 is a novel PPAR target gene.

Authors:  Fokko Zandbergen; Stéphane Mandard; Pascal Escher; Nguan Soon Tan; David Patsouris; Tim Jatkoe; Sandra Rojas-Caro; Steve Madore; Walter Wahli; Sherrie Tafuri; Michael Müller; Sander Kersten
Journal:  Biochem J       Date:  2005-12-01       Impact factor: 3.857

3.  Overexpression of nucleolin in chronic lymphocytic leukemia cells induces stabilization of bcl2 mRNA.

Authors:  Yoko Otake; Sridharan Soundararajan; Tapas K Sengupta; Ebenezer A Kio; James C Smith; Mauricio Pineda-Roman; Robert K Stuart; Eleanor K Spicer; Daniel J Fernandes
Journal:  Blood       Date:  2007-04-01       Impact factor: 22.113

4.  Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome.

Authors:  G Q Daley; R A Van Etten; D Baltimore
Journal:  Science       Date:  1990-02-16       Impact factor: 47.728

5.  MethPrimer: designing primers for methylation PCRs.

Authors:  Long-Cheng Li; Rajvir Dahiya
Journal:  Bioinformatics       Date:  2002-11       Impact factor: 6.937

6.  Gene expression profiling of CD34+ cells identifies a molecular signature of chronic myeloid leukemia blast crisis.

Authors:  C Zheng; L Li; M Haak; B Brors; O Frank; M Giehl; A Fabarius; M Schatz; A Weisser; C Lorentz; N Gretz; R Hehlmann; A Hochhaus; W Seifarth
Journal:  Leukemia       Date:  2006-06       Impact factor: 11.528

7.  Long-range mapping of the Philadelphia chromosome by pulsed-field gel electrophoresis.

Authors:  C A Westbrook; C M Rubin; J J Carrino; M M Le Beau; A Bernards; J D Rowley
Journal:  Blood       Date:  1988-03       Impact factor: 22.113

Review 8.  DNA methylation profiling in the clinic: applications and challenges.

Authors:  Holger Heyn; Manel Esteller
Journal:  Nat Rev Genet       Date:  2012-09-04       Impact factor: 53.242

9.  The cytosolic protein G0S2 maintains quiescence in hematopoietic stem cells.

Authors:  Takeshi Yamada; Chun Shik Park; Audrea Burns; Daisuke Nakada; H Daniel Lacorazza
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

10.  Identification of a protein, G0S2, that lacks Bcl-2 homology domains and interacts with and antagonizes Bcl-2.

Authors:  Christian Welch; Manas K Santra; Wissal El-Assaad; Xiaochun Zhu; Wade E Huber; Richard A Keys; Jose G Teodoro; Michael R Green
Journal:  Cancer Res       Date:  2009-08-25       Impact factor: 12.701

View more
  17 in total

1.  Human anti-nucleolin recombinant immunoagent for cancer therapy.

Authors:  Dario Palmieri; Timothy Richmond; Claudia Piovan; Tyler Sheetz; Nicola Zanesi; Fulvia Troise; Cindy James; Dorothee Wernicke; Fata Nyei; Timothy J Gordon; Jessica Consiglio; Francesco Salvatore; Vincenzo Coppola; Flavia Pichiorri; Claudia De Lorenzo; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-13       Impact factor: 11.205

2.  The sparing use of fat: G0s2 controls lipolysis and fatty acid oxidation.

Authors:  Christoph Heier; Robert Zimmermann
Journal:  Diabetologia       Date:  2014-10-29       Impact factor: 10.122

3.  G0S2 represses PI3K/mTOR signaling and increases sensitivity to PI3K/mTOR pathway inhibitors in breast cancer.

Authors:  Christina Y Yim; Emmanuel Bikorimana; Ema Khan; Joshua M Warzecha; Leah Shin; Jennifer Rodriguez; Ethan Dmitrovsky; Sarah J Freemantle; Michael J Spinella
Journal:  Cell Cycle       Date:  2017-09-14       Impact factor: 4.534

Review 4.  G0S2: A small giant controller of lipolysis and adipose-liver fatty acid flux.

Authors:  Xiaodong Zhang; Bradlee L Heckmann; Latoya E Campbell; Jun Liu
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2017-06-21       Impact factor: 4.698

5.  Mice lacking G0S2 are lean and cold-tolerant.

Authors:  Tian Ma; Alexandra G N Lopez-Aguiar; Aihua Li; Yun Lu; David Sekula; Eugene E Nattie; Sarah Freemantle; Ethan Dmitrovsky
Journal:  Cancer Biol Ther       Date:  2014-02-20       Impact factor: 4.742

6.  G0S2 Suppresses Oncogenic Transformation by Repressing a MYC-Regulated Transcriptional Program.

Authors:  Christina Y Yim; David J Sekula; Mary P Hever-Jardine; Xi Liu; Joshua M Warzecha; Janice Tam; Sarah J Freemantle; Ethan Dmitrovsky; Michael J Spinella
Journal:  Cancer Res       Date:  2016-02-02       Impact factor: 12.701

7.  G0/G1 Switch Gene 2 Regulates Cardiac Lipolysis.

Authors:  Christoph Heier; Franz P W Radner; Tarek Moustafa; Renate Schreiber; Susanne Grond; Thomas O Eichmann; Martina Schweiger; Albrecht Schmidt; Ines K Cerk; Monika Oberer; H-Christian Theussl; Jacek Wojciechowski; Josef M Penninger; Robert Zimmermann; Rudolf Zechner
Journal:  J Biol Chem       Date:  2015-09-08       Impact factor: 5.157

8.  G0S2 modulates homeostatic proliferation of naïve CD8⁺ T cells and inhibits oxidative phosphorylation in mitochondria.

Authors:  Ping-Hsien Lee; Takeshi Yamada; Chun Shik Park; Ye Shen; Monica Puppi; H Daniel Lacorazza
Journal:  Immunol Cell Biol       Date:  2015-02-10       Impact factor: 5.126

9.  A peptide derived from G0/G1 switch gene 2 acts as noncompetitive inhibitor of adipose triglyceride lipase.

Authors:  Ines K Cerk; Barbara Salzburger; Andras Boeszoermenyi; Christoph Heier; Christoph Pillip; Matthias Romauch; Martina Schweiger; Irina Cornaciu; Achim Lass; Robert Zimmermann; Rudolf Zechner; Monika Oberer
Journal:  J Biol Chem       Date:  2014-09-25       Impact factor: 5.157

10.  Inhibition of adipose triglyceride lipase (ATGL) by the putative tumor suppressor G0S2 or a small molecule inhibitor attenuates the growth of cancer cells.

Authors:  Rachid Zagani; Wissal El-Assaad; Isabelle Gamache; Jose G Teodoro
Journal:  Oncotarget       Date:  2015-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.